메인콘텐츠 바로가기

봉생기념병원 (BONGSENG MEMORIAL HOSPITAL est. 1949) 의료진/진료과

이전 페이지로 이동
통합검색 입력란
전체메뉴
전체메뉴 닫기

> 의료진/진료과 > 의료진/진료과 > 신장내과 > 의료진

신장내과

신장내과
오준석 내과부장

진료분야

신장이식, 혈액투석, 복막투석, 당뇨병성 신병증

진료일정 (20241118 ~ 20241123)

의료진/진료과 - 의료진 진료일정 정보표 : 요일/시간, 월요일, 화요일, 수요일, 목요일, 금요일, 토요일, 오전, 오후 진료일정에 관한 정보제공
요일/시간
오전 진료 진료 진료 진료 투석 진료
오후 진료 투석 진료 투석 투석
진료
진료
시술
시술
투석
투석

학력/경력

  • 부산대학교 의과대학 졸업
  • 동아대학교 대학원 의학석사 취득
  • 동아대학교 대학원 의학박사 취득
  • 부산대학교병원 인턴 수료
  • 봉생기념병원 레지던트 수료
  • 내과 전문의 자격취득
  • 신장내과 분과전문의 자격 취득
  • 신장투석전문의 자격 취득
  • 미국 하버드의과대학교 리서치 펠로우(2018.08-2019.07)
  • Brigham & Women's Hospital 교환 교수(2018.08-2019.07)

학회활동

  • 대한내과학회 정회원
  • 대한이식학회 정회원
  • 대한신장학회 정회원
  • 미국이식학회 정회원
  • 미국신장학회 정회원
  • 세계이식학회 정회원
  • 대한투석혈관학회 정회원
  • 대한신장학회 인공신장실 인증평가위원
  • Korea Organ Transplantation Registry 신장위원회 위원
  • 현 대한이식학회 이사
  • 현 대한이식학회 재무위원회 위원
  • 현 대한신장학회 부울경지회 총무이사
  • 현 대한신장학회 영남내과계 신이식연구회 총무

주요 논문(및 저서)

  1. 1. Comparison of heart rate variability between end stage renal disease patients on hemodialysis and hypertensive patients (The Korean Journal of Medicine: Vol. 75, No 1: .54~59, 2008)
  2. 2. Leflunomide Treatment in BK Virus Associated Nephropathy after Renal Transplantation (The Korean Journal of Nephrology: Vol. 28, No. 3, 2009)
  3. 3. Clinical outcome of kidney transplantation in patients with diabetic nephropathy (The Korean Journal of Medicine: Vol. 77, No. 3, 2009)
  4. 4. A Case of Asymptomatic Disseminated Cryptococcosis in Renal Transplant Patient (The Korean Journal of Nephrology: Vol. 29, No.2, 2010)
  5. 5. Rituximab and Plasmapheresis for Post-Transplant Recurrence of FSGS (The Korean Journal of Nephrology: Vol. 29, No. 2, 2010)
  6. 6. A Case of Reversible Posterior Leukoencephalopathy Syndrome in a Patient with ABO Incompatible Kidney Transplantation (The Korean Journal of Nephrology: Vol. 29, No. 2, 2010)
  7. 7. Comparison of heart rate variability between ESRD patients on peritoneal Dialysis and hypertensive patients (The Korean Journal of Medicine: Vol. 78, No.6, 2010)
  8. 8. Combination Treatment of Rituximab and Plasmapheresis in Acute Cellular Rejection with Focal Segmental Glomerular Sclerosis after Renal Transplantation (The Journal of the Korean Society of Transplantation: Vol.24, No.1, Mar, 2010)
  9. 9. Clinical Outcomes of Preemptive Kidney Transplantation in Patients with Diabetes Mellitus (Transplantation Proceedings, Vol. 42, 3497- 3502, 2010)
  10. 10. Intraperitoneal Paricalcitol Treatment for Secondary Hyperparathyroidism in CAPD patient: A Case Report (The Korean Journal of Nephrology: Vol.30, No.2, 2011)
  11. 11. Reliability of Hemodialysis Adequacy Measured by lonic Dialysance (The Korean Journal of Nephrology: Vol.30, No.3, 2011)
  12. 12. Case of ABO-Incompatible Living Donor Kidney Transplantation without Blood Products in a Jehovah’s Witness (The Journal of the Korean Society of Transplantation: Vol. 25, No. 1, Mar.2011)
  13. 13. A Case of Late Mixed Acute Humoral and Cellular Rejection Successfully Treated with Rituximab, Plasmapheresis and IVIG (The Journal of the Korean Society of Transplantation: Vol. 25, No. 2, June, 2011)
  14. 14. Successful treatment of Vancomycin-Resistant Enterococci Peritonitis with Quinupristin/ Dalfopristin in a Patient on Continuous Ambulatory Peritoneal Dialysis (The Korean Journal of Medicine: Vol.80 Suppl.2, 2011)
  15. 15. Comparison of Heart Rate Variability in Kidney Transplantation and End-Stage Renal Disease Patients on Dialysis (The Korean Journal of Medicine; Vol. 83, No 5, 606-612, 2012)
  16. 16. Etoposide induces a mixed type of programmed cell deathand overcomes the resistance conferred by Bcl-2 in Hep3B hepatoma cells (International Journal of Oncology Vol. 41, 1443-1454, 2012)
  17. 17. Acute Renal Failure in a Renal Allograft Recipient Caused by a Post-Biopsy Renal Arteriovenous Fistula with Transplant Renal Artery Stenosis (The Journal of Korean society of Transplantation; Vol. 26:287-292, 2012)
  18. 18. Comparison of Erythrocyte Membrane Fatty Acid Contents in Renal Transplant Recipients and Dialysis Patients (Transplantation proceedings: Vol 44 Issue 10, 2932-5, 2012)
  19. 19. The targeted inhibition of mitochondrial Hsp90 overcomes the apoptosis resistance conferred by Bcl-2 in Hep3B cells via necroptosis (Toxicology and Applied Pharmacology Vol. 266, 9–18, 2013)
  20. 20. Retinal pigment epithelial cells undergoing mitotic catastrophe are vulnerable to autophagy inhibition (Cell Death and Disease Vol. 5, e1303, 2014)
  21. 21. A Case of Squamous Cell Carcinoma in Nasal Cavity Treated with Conversion to Sirolimus in a Patient with Kidney Transplantation (The Journal of Korean society of Transplantation: Vol.28:83-86,2014)
  22. 22. Using Sirolimus for Posttransplant Management and Reduction of Tuberous Sclerosis Complex Progression in a Patient with End Stage Renal Disease Caused by Tuberous Sclerosis Complex (The Journal of Korean society of Transplantation: Vol.28:241-245, 2014)
  23. 23. Treatment of acute antibody-mediated rejection using bortezomib: a case report. (Nephrology 2015 Jul;20 Suppl 2:86-9)
  24. 24. Dietary Analysis of Kidney Transplant Patients Who Eat Korean Foods: Single Center Study (The Journal of Korean society of Transplantation; Vol. 29:68-74, 2015)
  25. 25. Successful Balloon Angioplasty with Low-pressure Balloon on Early Transplant Renal Artery Stenosis at Postoperative Day 7 (The Journal of Korean society of Transplantation: Vol.30: 103-107,2016)
  26. 26. Efficacy of Ultralow-Dose Valganciclovir Chemoprophylaxis for Cytomegalovirus Infection in ABO-Incompatible Kidney Transplantation Recipients (Transplant proceedings 2018 Oct;50(8):2485-2488)
  27. 27. Placement of tunneled cuffed catheter for hemodialysis: Micropuncture kit versus Angiocath IV catheter. (J Vasc Access 2019 May;20(1_suppl):50-54)
  28. 28. Long-term Survival Analysis of Kidney Transplant Recipients Receiving Mizoribine as a Maintenance Immunosuppressant: A Single-Center Study (Transplant Proceedings 2019 Oct;51(8):2637-2642)
  29. 29. Efficacy and Safety of Ultra-Low-Dose Valganciclovir Chemoprophylaxis for Cytomegalovirus Infection in High-Risk Kidney Transplantation Patients. (Transplant Proceedings 2019 Oct;51(8):2689-2692)
  30. 30. Changes in the glymphatic system before and after dialysis initiation in patients with end-stage kidney disease (Renal Failure 2023;45(2):2265665)